University of California San Francisco
Give to UCSFThe United States health system is poorly equipped to serve patients living alone who are also experiencing cognitive decline.
Study finds DOACs may lower recurrent VTE risk over warfarin in extended treatment. Observational evidence supports DOAC use.
A newly identified platelet factor 4 (PF4) was found to help rejuvenate the old brain and boost the young brain, potentially opening the door to new therapies that aim to restore brain function
Increasing wildfires means there is more wildfire smoke, which is particularly harmful for our bodies.
A new digital headset designed to measure alterations in brain function could change decisions about how quickly an athlete is ready to return to play after a concussion.
Long COVID symptoms can persist for a year after initial infection, or re-emerge months later after disappearing.
Benjamin N. Breyer, MD, MAS, FACS, a renowned leader in urology and urological surgery, has been appointed chair of the UCSF Department of Urology.
Adverse experiences early in childhood and early life have been linked to lifelong health consequences.
Millions of Americans with tobacco-related disease have symptoms that don't fit any existing tobacco-disease criteria
An experimental blood test that reflects injury to nerve cells from multiple sclerosis (MS) was found to work for children with MS and other neurological conditions, even when they are symptom-free.
Toxic dust from artificial stone slabs popular in kitchen countertops in the U.S. is causing a rising numbers in lung disease among stone workers.